BEAMSTART Logo

HomeNews

SC to hear pleas over Rs 50 lakh cap on Centre aid for rare diseases

Business Standard LogoBusiness Standard2w ago

SC to hear pleas over Rs 50 lakh cap on Centre aid for rare diseases - Business Standard

Quick Summary:

The Supreme Court on Tuesday decided to examine pleas challenging the Rs 50 lakh cap on Centre's assistance for treating patients suffering from rare diseases like spinal muscular atrophy (SMA).

The bench said pharma firm M/s F Hoffmann-La Roche Ltd, which manufactures the SMA drug Risdiplam priced at Rs 6.2 lakh a bottle, had agreed to supply the medicine for free for a year to 24-year-old Seba PA, who hails from Kerala, and suffers from the disorder.

A bench comprising Chief Justice Sanjiv Khanna and Justice Sanjay Kumar said the petitions on the cap of Rs 50 lakh central assistance to treat diseases would be heard by a bench headed by Justice P S Narasimha in the week commencing May 13.


More Pictures

SC to hear pleas over Rs 50 lakh cap on Centre aid for rare diseases - Business Standard (Picture 1)

or

Article Details

Category: BusinessFinance

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-04-08 @ 17:51:29 (2 weeks ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 810 words

Reading Time: 5 minutes read

Sentences: 33 lines

Sentence Length: 25 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 27726575

View Article Analysis

About Business Standard

Business Standard Logo

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 263 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "SC to hear pleas over Rs 50 lakh cap on Centre aid for rare diseases" has 810 words across 33 sentences, which will take approximately 4 - 7 minutes for the average person to read.

Which news outlet covered this story?

The story "SC to hear pleas over Rs 50 lakh cap on Centre aid for rare diseases" was covered 2 weeks ago by Business Standard, a news publisher based in India.

How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news.

The outlet is headquartered in India and publishes an average of 263 news stories per day.

It's most recent story was published 2 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #27726575
  • URL: https://encashes.beamstart.com/news/sc-to-hear-pleas-over-17441152933073

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.